| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4582190
Max Phase: Preclinical
Molecular Formula: C9H21N3O
Molecular Weight: 187.29
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: CCCCCNC(=N)NCCOC
Standard InChI: InChI=1S/C9H21N3O/c1-3-4-5-6-11-9(10)12-7-8-13-2/h3-8H2,1-2H3,(H3,10,11,12)
Standard InChI Key: ONGYOPVODVLOHL-UHFFFAOYSA-N
Associated Targets(Human)
N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 231 Activities
Nitric-oxide synthase, brain 1786 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Nitric-oxide synthase, endothelial 1452 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Nitric oxide synthase, inducible 1636 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Associated Targets(non-human)
Arginase-1 70 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 187.29 | Molecular Weight (Monoisotopic): 187.1685 | AlogP: 0.94 | #Rotatable Bonds: 7 |
| Polar Surface Area: 57.14 | Molecular Species: BASE | HBA: 2 | HBD: 3 |
| #RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 12.56 | CX LogP: 1.04 | CX LogD: -1.37 |
| Aromatic Rings: 0 | Heavy Atoms: 13 | QED Weighted: 0.32 | Np Likeness Score: -0.32 |
References
| 1. Lunk I, Litty FA, Hennig S, Vetter IR, Kotthaus J, Altmann KS, Ott G, Havemeyer A, Carrillo García C, Clement B, Schade D.. (2020) Discovery of N-(4-Aminobutyl)-N'-(2-methoxyethyl)guanidine as the First Selective, Nonamino Acid, Catalytic Site Inhibitor of Human Dimethylarginine Dimethylaminohydrolase-1 (hDDAH-1)., 63 (1): [PMID:31841335] [10.1021/acs.jmedchem.9b01230] |
Source
Source(1):